Privi Speciality Chemicals Limited — Investor Meet, 15-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Privi Speciality Chemicals posted strong FY26 results: Revenue grew 21.73% to ₹2,582.92 Cr, EBITDA surged 40.35% to ₹665.45 Cr (25.76% margin), and PAT climbed 75.16% to ₹327.54 Cr. Management projects 20% growth next year, sustaining 20%+ EBITDA margins, aiming for ₹5,000 Cr revenue & ₹1,000 Cr+ EBITDA in 3-4 years. Operational highlights include increasing capacity to 54,000 MT/annum by June 2026. The PRIGIV JV turned profitable, targeting ₹130 Cr sales this year. New speciality products & biotech initiatives drive confidence in strategic growth and value creation.